Corimmun GmbH
News and Media
http://www.corimmun.com/news-and-media.html

© 2010 Corimmun GmbH

Address

Corimmun GmbH
Fraunhoferstr. 17

Lieferanschrift:
Lochhamer Str. 29, Rückgebäude
D-82152 Martinsried
Germany

Tel: 0049-(0)89-8565 2010
Fax: 0049-(0)89-8565 2020
Email: info@corimmun.com
HR B 165022
Amtsgericht München

Geschäftsführer:

Martin Ungerer
Götz Münch

International

News and Media

Press Announcement 05.07.2010

Corimmun Has Received Funding within the “m4 – Personalized Medicine” Cluster Initiative

Press Announcement 15.3.2010

Corimmun Has Successfully Completed a Phase I Clinical Trial with its Lead Compound COR-1

Press Announcement 25.11.2009

Corimmun Has Successfully Started a Phase I Clinical Trial
with its Lead Compound COR-1
[184 KB]

Press Announcement 10.2008

5 Mio Euro in Series A... PDF Document [184 KB]

Press Announcement 10.2008

Venture Capital for Corimmun... PDF Document [577 KB]

Press Announcement 22.08.2008

Corimmun GmbH closes a 5 Million Euro financing... PDF Document [41 KB]

Corimmun - Förderung statt VC

Förderung statt VC [88 KB]

Neue Gründerwelle -Die 50 interessantesten Gründer

Handelsblatt 19.04.2007 [113 KB]

Finanzierung für Corimmun

Finanzierungsrunde mit dem High-Tech Gründerfonds [22 KB]